Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Une patiente et un médecin

Centre for Clinical Investigation Neurosciences

Last update: 28/05/2025 Reading time: 1min

Created in 1995, the Centre d’Investigation Clinique (CIC) Neurosciences is a clinical research platform dedicated to diseases of the nervous system. It is located in the heart of Paris Brain Institute.

What is the CIC Neurosciences?

What is the CIC Neurosciences?

The Centre d’Investigation Clinique (CIC) Neurosciences is a day hospital and clinic unit dedicated to clinical research on diseases of the nervous system.

The CIC Neurosciences has dedicated premises and staff trained in clinical research for the study of neurological and psychiatric diseases in optimum conditions of quality, ethics and safety. The main pathologies studied are: Parkinson’s disease, multiple sclerosis (MS), dementias, neurogenetics, neuropsychiatry, amyotrophic lateral sclerosis (ALS), peripheral neuropathies, epilepsy.
 

Since its creation in 2010, a major effort has been made to structure clinical research and it can now be said that Paris Brain Institute is a driving force for clinical research at the Pitié-Salpêtrière Hospital, one of the most renowned centres of neurology and psychiatry in the world.

Pr Catherine LUBETZKI Neurologist (AP-HP, Sorbonne University), Director of the Medical-University Department (DMU) of the Pitié-Salpétrière Hospital, Medical Director of Paris Brain Institute and leader of the team "remyelination in multiple sclerosis"
Understanding in 2 Minutes: the CIC Neurosciences
Le CIC Neurosciences
Neurosciences CIC

The CIC Neurosciences collaborates closely with the doctors of the Department of Medical-University (DMU) Neurosciences AP-HP Sorbonne University, the research teams of Paris Brain Institute, and the drug manufacturers for therapeutic trials. The aim of the studies carried out is to gain a better understanding of the pathologies affecting the nervous system and to offer patients access to innovative therapeutics.

The CIC Neurosciences Today

The CIC Neurosciences Today

Today, the CIC Neurosciences within Paris Brain Institute coordinates about 80 clinical trials initiated by public investigators (about 60%) and by industrialists (about 40%). Half of these trials are therapeutic, about 25% are pathophysiologic, and about 25% are clinically and biologically characterized cohorts.

Le Centre d’Investigation Clinique Neurosciences est situé au premier étage de l’Institut du Cerveau
The Neuroscience Clinical Investigation Center is located on the first floor of Paris Brain Institute.

Contact the CIC Neuroscientists

Contact the CIC Neuroscientists
 

To contact the Centre for Clinical Investigation (CIC) Neurosciences:

Click here

News that might interest you

Le développement du cerveau a une part d’aléatoire
The stochastic aspect of brain development
Although every person’s personality is the result of genetic and environmental factors, these are not the only factors at play. Bassem Hassan and his team at Paris Brain Institute have discovered that, in fruit flies (drosophila), individuality also...
05.12.2025 Research, science & health
Analyse MERSCOPE
New treatment pathways for brain malformation-linked focal epilepsy?
A study by Stéphanie Baulac’s team has revealed somatic mutations in different cell types in patients with type 2 focal cortical dysplasia. This disease causes drug-resistant epileptic seizures, for which the main treatment option is currently...
05.12.2025 Research, science & health
Un iceberg
The ICEBERG cohort, 10 years of collective scientific and medical mobilization
The ICEBERG cohort, initiated 10 years ago, is interested in studying factors predictive of the onset and progression of Parkinson’s disease.
05.15.2025 Research, science & health
La huntingtine est une protéine indispensable au développement embryonnaire, à la formation et au maintien du tissu cérébral.
Huntington's Disease: The Energy Hypothesis Gets Traction
Huntington's disease, a rare hereditary neurological disorder, is associated with an energy deficit that precedes the onset of symptoms and is closely linked to their progression. At Paris Brain Institute, Fanny Mochel and her colleagues are testing...
02.11.2025 Research, science & health
À la recherche de marqueurs d’imagerie dans la démence frontotemporale
Searching for Imaging Markers in Frontotemporal Dementia
Could exploring the relationships between different brain networks help us understand frontotemporal dementia (FTD)? This neurodegenerative disease, which progresses at varying rates, is often diagnosed late—when clinical signs are already severe. At...
01.07.2025 Research, science & health
Monocyte – un globule blanc qui se différencie en macrophage. Crédit : Université d’Edinbourg.
Discovery of a Macrophage Anomaly in Multiple Sclerosis
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
12.19.2024 Research, science & health
See all our news